Opendata, web and dolomites

CENTR-ALL SIGNED

Clarifying role of the CENTROSOME in abnormal mitotic processes featuring the most commonchildhood malignancy: paediatric High Hyperdiploid Acute Lymphoblastic Leukaemia (HHDpALL)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 CENTR-ALL project word cloud

Explore the words cloud of the CENTR-ALL project. It provides you a very rough idea of what is the project "CENTR-ALL" about.

variance    genomics    capacity    amplification    personal    frequent    alwin    ultrastructural    original    accordingly    paediatric    screening    avenue    dkfz    germany    world    illuminate    kr    fluorescence    lymphoblastic    cross    diagnostic    auml    critical    evaluation    opposed    academic    showed    electron    hhd    researcher    primary    centrosomes    methodology    retain    solid    cells    gains    inhibiting    mer    ca    malignancies    pathomechanism    aflm    schwab    therapeutics    pattern    leader    leukaemia    centrosome    institutes    accounts    headed    therapeutic    indicate    mostly    clarified    viability    children    cin    join    immunocytochemistry    abnormalities    building    functional    microscopy    throughput    acute    sequential    er    first    issue    correlative    hematologic    desirable    light    featured    time    visualized    laboratory    poorly    prone    align    chromosomal    error    tumour    cell    evolvement    scanning    biology    hhdpall    technologies    professor    precise    metasystems    hcclem    cancer    potentials    commercial    clustering    group    automated    pall    embl    mechanism    instability    hyperdiploidy    et    image    gain    inter    al    deaths   

Project "CENTR-ALL" data sheet

The following table provides information about the project.

Coordinator
DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG 

Organization address
address: IM NEUENHEIMER FELD 280
city: HEIDELBERG
postcode: 69120
website: www.dkfz.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 171˙460 €
 EC max contribution 171˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2017
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-01-24   to  2021-01-23

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG DE (HEIDELBERG) coordinator 171˙460.00

Map

 Project objective

Paediatric Acute Lymphoblastic Leukaemia (pALL) still accounts for most cancer-related deaths in children. Although high hyperdiploidy (HHD) is the most frequent pattern, its pathomechanism remains poorly understood. Recently, Experienced Researcher (ER) et al showed that sequential chromosomal gains and chromosomal instability (CIN) are critical features in HHD-pALL evolvement. The most common cause of CIN is centrosome amplification (CA) and recent findings indicate that inhibiting centrosome clustering (mechanism by which tumour cells control CA to retain viability) is a promising therapeutic avenue. Opposed to most solid and hematologic malignancies, the role of CA in HHDpALL has not been clarified thus far. Primary goal of ER is to illuminate this issue, which is expected to result in new diagnostic- and screening methodologies, as well as novel therapeutics. ER will join a leading group in the field of ‘cancer associated centrosome abnormalities’ (headed by Professor Alwin Krämer), in one of Europe’s largest cancer research institutes (DKFZ, Germany), applying state-of the art technologies in genomics and functional cell biology. Centrosomes are mostly visualized by immunocytochemistry, but precise evaluation is error prone and featured with inter-personal/-laboratory variance. A diagnostic and high-throughput screening methodology thus is highly desirable. Accordingly, second aim is to develop a novel automated fluorescence light microscopy (aFLM) application for centrosome analysis, building on ER's previous experience, but in a cross-sector collaboration with a non-academic world leader in image analysis (MetaSystems, Germany). To gain ultrastructural information as well, ER will also align aFLM with scanning electron microscopy for the first time, in collaboration with the Schwab Group (EMBL, Germany) creating high-capacity correlative light electron microscopy (hcCLEM). Commercial potentials of above original developments will also be investigated.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CENTR-ALL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CENTR-ALL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

EngPTC2 (2019)

Exploring new technologies for the next generation pulse tube cryocooler below 2K

Read More  

BB-SLM (2020)

Polychromatic digital optics for structured light

Read More  

NSTree (2020)

Understanding substrate delivery for cell wall biosynthesis in plants

Read More